<p>Current colorectal cancer mouse models either lack colon specificity, limiting progression towards more advanced disease, or preclude evaluation of resident stem cells as cancer origins. Here we report the identification of NOX1 and NPY1R as cell-surface markers enriched in LGR5<sup>+</sup> stem cells predominantly within the caecum and exclusively within the middle and distal colorectum, respectively. Selective dysregulation of Wnt signalling in NOX1<sup>+</sup> or NPY1R<sup>+</sup> stem cells using <i>CreERT2</i> mouse lines drives colon cancer initiation, predominantly within the caecum and rectum respectively, establishing these stem cell populations as important sources of colon cancer. Selective conditional activation of Wnt signalling and oncogenic <i>Kras</i> in combination with loss of TRP53 in these stem cell compartments resulted in the development of advanced, invasive cancers. This study establishes <i>CreERT2</i> drivers as valuable tools for studying stem cell contributions to colon cancer.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

NOX1 and NPY1R mark regional colon stem cell populations that serve as cancer origins in vivo

  • Maxime Gasnier,
  • Tanysha Chi-Ying Chen,
  • Swathi Yada,
  • Sowmya Sagiraju,
  • Yusuke Yoshikawa,
  • Stefano Perna,
  • Hui Yi Grace Lim,
  • Bernett Lee,
  • Nick Barker

摘要

Current colorectal cancer mouse models either lack colon specificity, limiting progression towards more advanced disease, or preclude evaluation of resident stem cells as cancer origins. Here we report the identification of NOX1 and NPY1R as cell-surface markers enriched in LGR5+ stem cells predominantly within the caecum and exclusively within the middle and distal colorectum, respectively. Selective dysregulation of Wnt signalling in NOX1+ or NPY1R+ stem cells using CreERT2 mouse lines drives colon cancer initiation, predominantly within the caecum and rectum respectively, establishing these stem cell populations as important sources of colon cancer. Selective conditional activation of Wnt signalling and oncogenic Kras in combination with loss of TRP53 in these stem cell compartments resulted in the development of advanced, invasive cancers. This study establishes CreERT2 drivers as valuable tools for studying stem cell contributions to colon cancer.